StockData
Oculis Holding AG logo

Oculis Holding AG (OCS) stock

OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 4, 2026Score 1/30
$7.44+0.05 (+0.68%)

Close on Nov 19, 2026Market cap $447.07MP/E –Yield –

Oculis free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -CHF 66.61M. The highest annual figure on record is -CHF 12.05M in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-CHF 66.61M–
FY2024Dec 31, 2024-CHF 49.15M–
FY2023Dec 31, 2023-CHF 55.09M–
FY2022Dec 31, 2022-CHF 25.14M–
FY2021Dec 31, 2021-CHF 13.85M–
FY2020Dec 31, 2020-CHF 12.05M–

More Oculis figures

See a number that looks wrong?